Furthermore, pharmacological or genetic suppression of oxidative stress and cellular toxicity induced by poly(GR) decreases DNA damage, indicating reducing oxidative stress is a potential therapeutic strategy for C9orf72-linked ALS/FTD (Lopez-Gonzalez et al., 2016). This evidence concerns the gene C9orf72 and frontotemporal dementia.